Hemogenyx Pharmaceuticals Plc (HEMO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 06-2025 | 12-2024 | 06-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,586 | 227 | 159 | 1,643 | 1,248 |
| Other current assets | 13 | 343 | 8 | 828 | 5 |
| TOTAL | $2,035 | $570 | $839 | $2,471 | $2,170 |
| Non-Current Assets | |||||
| PPE Net | 1,803 | 2,193 | 2,727 | 3,007 | 3,312 |
| Intangibles | 182 | 182 | 477 | 473 | 470 |
| Other Non-Current Assets | 157 | 157 | 168 | 166 | 154 |
| TOTAL | $2,141 | $2,531 | $3,373 | $3,646 | $3,936 |
| Total Assets | $4,176 | $3,101 | $4,212 | $6,116 | $6,106 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 965 | 909 | 683 | 309 | 302 |
| TOTAL | $1,470 | $1,323 | $1,159 | $564 | $652 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 51 | 581 | 44 | 40 | 38 |
| TOTAL | $1,562 | $2,325 | $2,199 | $2,529 | $2,673 |
| Total Liabilities | $3,031 | $3,648 | $3,358 | $3,093 | $3,325 |
| Shareholders' Equity | |||||
| Common Shares | 60 | 46 | 35 | 13,418 | 11,756 |
| Retained earnings | -38,751 | -34,428 | -29,424 | -26,618 | -23,805 |
| Other shareholders' equity | 10,646 | 10,955 | 8,898 | -5,173 | -5,071 |
| TOTAL | $1,195 | $-500 | $898 | $3,064 | $2,819 |
| Total Liabilities And Equity | $4,227 | $3,148 | $4,256 | $6,157 | $6,144 |